DURHAM, NC, November 19, 2025 /24-7PressRelease/ -- Jeanne Hecht has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Ms. Hecht, an accomplished executive with three decades of experience in pharmaceutical and med-tech innovation, currently serves as chief executive officer and executive chairwoman of Lexitas Pharma Services Inc., a role she has held since June of 2022. In this capacity, she leads the organization's strategic direction, spending significant time engaging with clients, KOLs, and industry partners to communicate Lexitas' unique expertise and their commitment to growth and innovation in ophthalmology. She also collaborates closely with banks and investors on behalf of clients, works alongside employees to address critical challenges and identifies opportunities to scale the business. Her responsibilities further include interacting with researchers, industry groups, life science companies, and cooperative groups to evaluate options for more effective clinical trials seeking innovative ways to accelerate drug development for patients affected by vision-altering diseases. Through her leadership, she aims to fundamentally change how people see the world.

In addition to her primary role at Lexitas Pharma Services Inc., Ms. Hecht is also the founder and chief executive officer of JTH Consulting & Associates, a consultancy she established in 2018 that provides strategic guidance to organizations within the life sciences sector. She has been a non-executive director at Veeda Clinical Research since 2021, AutoCruitment since 2022, JCCT since 2023, and Castor since 2023. Her investment interests include Ripple Science since 2021 and BEKHealth since 2022. Since 2008, she has served as chief executive officer and founding owner of Cassidy Investment Partners LLC, where she oversees investment strategies in real estate.

Ms. Hecht's expertise is further recognized through her advisory roles. She has been an industry advisory board member at Rho since 2021 and previously contributed as a non-executive director at Pro-ficiency from 2020 to 2024 and MMS from 2022 to 2023. She was strategic advisor and chair of the industry and scientific advisory board for 2020 On-site from 2020 to 2022, strategic advisor at Javara from 2018 to 2022, non-executive director at Vectura Group PLC from 2020 to 2021 and strategic advisor at EyeKor Inc. in 2021.

Her executive leadership extended to Ora Inc., where she was chief executive officer from 2019 to 2020 after serving as chief strategy officer in 2019 and as board member and consultant from 2018 to 2019. At Median Technologies, Ms. Hecht was chief operating officer and board member from 2016 to 2018.

Ms. Hecht's tenure at IQVIA (formerly Quintiles) marked a pivotal period in her career. As senior vice president, global head of site and patient networks from 2014 to 2016, she led global initiatives in clinical trial operations. From 2012 to 2014, she was senior vice president, global head of sales. Notably, as vice president, head of Asia sales and strategic planning from 2010 to 2012, she pioneered business development efforts in Asia, growing sales from $7 million to almost $1 billion within just 18 months—a milestone that established her as a leading commercial-minded executive in her field. This achievement remains one of her most significant professional accomplishments. She also played a key role in setting up new business lines and partnering with early-stage companies to achieve major growth milestones during her time at IQVIA.

Prior to her tenure at IQVIA, Ms. Hecht was vice president of sales and marketing at Decision Biomarkers from 2005 to 2007. She began her career in regulatory affairs as regulatory affairs officer at the University of North Carolina Oncology Protocol Office from 1999 to 2000 after serving as senior regulatory associate there from 1998 to 1999 and a records management administrator at Parke-Davis in Ann Arbor in 1998. Her professional journey began in education as a teacher for intermediate school students at ASSETS School for the Gifted/Dyslexic Student in Hawaii from 1995 to 1998 before transitioning into regulatory affairs.

Throughout her distinguished career, Ms. Hecht has developed expertise in full-service ophthalmic clinical trial development and leadership within pharmaceutical and med-tech innovation, an achievement that reflects her commitment to advancing patient care through science-driven solutions.

Ms. Hecht's academic background includes a Master of Business Administration earned from the University of Michigan Stephen M. Ross School of Business in Ann Arbor in 2007 following completion of a bachelor's degree at the University of Michigan in Ann Arbor in 1995. She further enhanced her credentials by obtaining a certificate of project management from the Project Management Institute in 2021.

Beyond her corporate achievements, Ms. Hecht is actively involved with civic-minded organizations, including service as CBOH board member for UNC Kenan-Flagler Business School since 2017; board member for the school's "100 Women" initiative from 2020 to 2022; advisory member for Greater Gift from 2018 to 2019; board member for Senior PharmAssist from 2018 to 2021; industry data sciences advisory board member for The University of North Carolina at Chapel Hill; volunteer for Kids=Play during 2018 and 2019; board member for Median Technologies from 2016 to 2018; board director for Sustain Foundation from 2008 to 2009; and volunteer with Ronald McDonald House Charities.

Her leadership excellence has been recognized through several prestigious awards, including CEO of the Year by Triangle Business Journal in 2025 and bronze winner for Woman of the Year at The Stevie Awards during the 23rd annual American Business Awards® in the same year. She attributes her success to authenticity, a can-do attitude and problem-solving mindset as well as lifelong curiosity and learning. Ms. Hecht emphasizes the importance of asking questions, leveraging professional networks and surrounding herself with capable individuals—qualities that have been instrumental throughout her career progression.

Outside of her professional commitments, Ms. Hecht enjoys hiking, skiing, scuba diving, reading, cooking, mentoring individuals, engaging in speech presentations and spending time with family. Looking ahead, she intends to continue transforming ophthalmic clinical research by scaling Lexitas Pharma Services globally while expanding access to vision-altering therapeutics through partnerships with leading researchers and ongoing team development, furthering innovative treatments for patients worldwide.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

# # #